u 78517f has been researched along with Body Weight in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, A; Sayyed, SG; Sharma, SS | 1 |
| Berrino, L; Falcone, G; Filippelli, A; Filippelli, W; Mastronardi, P; Mazzarella, B; Rossi, F; Tufano, R | 1 |
2 other study(ies) available for u 78517f and Body Weight
| Article | Year |
|---|---|
Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy.
Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Catalase; Chromans; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Hyperalgesia; Lipid Peroxidation; Male; Neural Conduction; Oxidative Stress; Piperazines; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Sciatic Nerve; Superoxide Dismutase | 2006 |
Cardiotoxicity of doxorubicin: effects of 21-aminosteroids.
Topics: Animals; Antineoplastic Agents; Antioxidants; Body Weight; Chromans; Doxorubicin; Electrocardiography; Heart; Heart Diseases; Male; Piperazines; Pregnatrienes; Rats; Rats, Wistar; Survival Rate | 1998 |